• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

M1和M4毒蕈碱型乙酰胆碱受体的晶体结构。

Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.

作者信息

Thal David M, Sun Bingfa, Feng Dan, Nawaratne Vindhya, Leach Katie, Felder Christian C, Bures Mark G, Evans David A, Weis William I, Bachhawat Priti, Kobilka Tong Sun, Sexton Patrick M, Kobilka Brian K, Christopoulos Arthur

机构信息

Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, Victoria, Australia.

ConfometRx, 3070 Kenneth Street, Santa Clara, California 95054, USA.

出版信息

Nature. 2016 Mar 17;531(7594):335-40. doi: 10.1038/nature17188. Epub 2016 Mar 9.

DOI:10.1038/nature17188
PMID:26958838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4915387/
Abstract

Muscarinic M1-M5 acetylcholine receptors are G-protein-coupled receptors that regulate many vital functions of the central and peripheral nervous systems. In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurological disorders, such as Alzheimer's disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors. Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium. Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family. We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.

摘要

毒蕈碱型M1 - M5乙酰胆碱受体是G蛋白偶联受体,可调节中枢和外周神经系统的许多重要功能。特别是,M1和M4受体亚型已成为治疗神经疾病(如阿尔茨海默病和精神分裂症)的有吸引力的药物靶点,但乙酰胆碱结合口袋的高度保守性促使目前对这些受体变构位点的靶向研究。在此,我们报道了与反向激动剂噻托溴铵结合的M1和M4毒蕈碱受体的晶体结构。将这些结构相互比较,以及与先前报道的M2和M3受体结构进行比较,揭示了正构和变构结合位点的差异,这些差异有助于在这个重要的受体家族中发挥药物选择性作用。我们还报道了鉴定出一组形成连接M4受体正构和变构位点网络的残基,这为变构调节如何在两个空间上不同的结构域之间传递提供了新的见解。

相似文献

1
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.M1和M4毒蕈碱型乙酰胆碱受体的晶体结构。
Nature. 2016 Mar 17;531(7594):335-40. doi: 10.1038/nature17188. Epub 2016 Mar 9.
2
Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.毒蕈碱型乙酰胆碱受体 M1 和 M4 作为神经退行性疾病药物靶点的现状。
Neuropharmacology. 2018 Jul 1;136(Pt C):449-458. doi: 10.1016/j.neuropharm.2018.01.028. Epub 2018 Jan 31.
3
New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).利用新型变构调节剂和DREADD(仅由设计药物激活的设计受体)对M4毒蕈碱型乙酰胆碱受体功能的新见解。
Mol Pharmacol. 2008 Oct;74(4):1119-31. doi: 10.1124/mol.108.049353. Epub 2008 Jul 15.
4
Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.开发一种放射性配体 [(3)H]LY2119620,以探测人源 M(2)和 M(4)毒蕈碱型乙酰胆碱受体变构结合位点。
Mol Pharmacol. 2014 Jul;86(1):116-23. doi: 10.1124/mol.114.091785. Epub 2014 May 7.
5
Positive allosteric modulation of M and M muscarinic receptors as potential therapeutic treatments for schizophrenia.正变构调节 M 和 M 毒蕈碱型乙酰胆碱受体作为精神分裂症的潜在治疗方法。
Neuropharmacology. 2018 Jul 1;136(Pt C):438-448. doi: 10.1016/j.neuropharm.2017.09.012. Epub 2017 Sep 9.
6
Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.M4 毒蕈碱型乙酰胆碱受体变构调节剂的作用机制及其体内验证,具有潜在的抗精神病特性。
Neuropsychopharmacology. 2010 Mar;35(4):855-69. doi: 10.1038/npp.2009.194. Epub 2009 Nov 25.
7
Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.硫胺素增强毒蕈碱M4受体处乙酰胆碱的亲和力:通过协同作用而非亲和力实现受体亚型选择性。
Mol Pharmacol. 2004 Jan;65(1):257-66. doi: 10.1124/mol.65.1.257.
8
Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.变构调节 G 蛋白偶联受体中的探针依赖性:对变构配体效应检测和验证的影响。
Mol Pharmacol. 2012 Jan;81(1):41-52. doi: 10.1124/mol.111.074872. Epub 2011 Oct 11.
9
The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.M1 毒蕈碱型乙酰胆碱受体变构激动剂 AC-42 和 1-[1'-(2-甲基苄基)-1,4'-联哌啶-4-基]-1,3-二氢-2H-苯并咪唑-2-酮与乙酰胆碱正位构象结合位点不同的独特结合位点结合。
Mol Pharmacol. 2010 Oct;78(4):648-57. doi: 10.1124/mol.110.065771. Epub 2010 Jul 21.
10
Bitopic Binding Mode of an M Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes.M 型乙酰胆碱受体激动剂的双结合模式与不良临床试验结局相关。
Mol Pharmacol. 2018 Jun;93(6):645-656. doi: 10.1124/mol.118.111872. Epub 2018 Apr 25.

引用本文的文献

1
De novo design of a fusion protein tool for GPCR research.用于GPCR研究的融合蛋白工具的从头设计。
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2422360122. doi: 10.1073/pnas.2422360122. Epub 2025 Jul 14.
2
From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M selective muscarinic receptor antagonist.从药效团预测到药物研发可能性:筛选M选择性毒蕈碱受体拮抗剂的综合方法
Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11208-4.
3
Is muscarinic receptor agonist effective and tolerant for schizophrenia?

本文引用的文献

1
Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis.修饰的T4溶菌酶融合蛋白促进G蛋白偶联受体晶体生成。
Structure. 2014 Nov 4;22(11):1657-64. doi: 10.1016/j.str.2014.08.022. Epub 2014 Oct 23.
2
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.对M1毒蕈碱型乙酰胆碱受体变构结构-功能关系的机制性见解。
J Biol Chem. 2014 Nov 28;289(48):33701-11. doi: 10.1074/jbc.M114.604967. Epub 2014 Oct 17.
3
Muscarinic acetylcholine receptors: novel opportunities for drug development.
毒蕈碱受体激动剂对精神分裂症有效且耐受性良好吗?
BMC Psychiatry. 2025 Apr 2;25(1):323. doi: 10.1186/s12888-025-06662-1.
4
Visualizing agonist-induced M2 receptor activation regulated by aromatic ring dynamics.可视化由芳环动力学调控的激动剂诱导的M2受体激活。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2418559122. doi: 10.1073/pnas.2418559122. Epub 2025 Mar 7.
5
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.G蛋白偶联受体的功能动力学揭示了药物发现的新途径。
Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2.
6
Extracellular Peptide-Ligand Dimerization Actuator Receptor Design for Reversible and Spatially Dosed 3D Cell-Material Communication.用于可逆和空间定量3D细胞-材料通信的细胞外肽-配体二聚化驱动受体设计
ACS Synth Biol. 2025 Jul 18;14(7):2494-2513. doi: 10.1021/acssynbio.4c00482. Epub 2024 Dec 20.
7
Positive allosteric modulation of a GPCR ternary complex.正向变构调节 G 蛋白偶联受体三聚体复合物。
Sci Adv. 2024 Sep 13;10(37):eadp7040. doi: 10.1126/sciadv.adp7040. Epub 2024 Sep 11.
8
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases.神经退行性疾病中毒蕈碱型乙酰胆碱受体调节的黄金时代。
Nat Rev Drug Discov. 2024 Oct;23(10):743-758. doi: 10.1038/s41573-024-01007-1. Epub 2024 Aug 14.
9
Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and perspectives.对用于降低眼压的胆碱能药物的深入见解:系统遗传学、分子建模及展望
Front Mol Biosci. 2024 Jul 26;11:1423351. doi: 10.3389/fmolb.2024.1423351. eCollection 2024.
10
Entropy drives the ligand recognition in G-protein-coupled receptor subtypes.熵驱动G蛋白偶联受体亚型中的配体识别。
Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2401091121. doi: 10.1073/pnas.2401091121. Epub 2024 Jul 18.
毒蕈碱型乙酰胆碱受体:药物研发的新机遇。
Nat Rev Drug Discov. 2014 Jul;13(7):549-60. doi: 10.1038/nrd4295. Epub 2014 Jun 6.
4
Allosteric and biased g protein-coupled receptor signaling regulation: potentials for new therapeutics.变构和偏向性G蛋白偶联受体信号调节:新疗法的潜力
Front Endocrinol (Lausanne). 2014 May 8;5:68. doi: 10.3389/fendo.2014.00068. eCollection 2014.
5
Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.开发一种放射性配体 [(3)H]LY2119620,以探测人源 M(2)和 M(4)毒蕈碱型乙酰胆碱受体变构结合位点。
Mol Pharmacol. 2014 Jul;86(1):116-23. doi: 10.1124/mol.114.091785. Epub 2014 May 7.
6
Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.新型正变构调节剂 LY2119620 对毒蕈碱 M(2)和 M(4)受体的特征描述。
Mol Pharmacol. 2014 Jul;86(1):106-15. doi: 10.1124/mol.114.091751. Epub 2014 May 7.
7
Muscarinic acetylcholine receptor X-ray structures: potential implications for drug development.毒蕈碱型乙酰胆碱受体的X射线结构:对药物开发的潜在影响。
Curr Opin Pharmacol. 2014 Jun;16:24-30. doi: 10.1016/j.coph.2014.02.006. Epub 2014 Mar 21.
8
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.M1 毒蕈碱型乙酰胆碱受体变构调节的分子决定因素。
J Biol Chem. 2014 Feb 28;289(9):6067-79. doi: 10.1074/jbc.M113.539080. Epub 2014 Jan 17.
9
Activation and allosteric modulation of a muscarinic acetylcholine receptor.毒蕈碱型乙酰胆碱受体的激活和变构调节。
Nature. 2013 Dec 5;504(7478):101-6. doi: 10.1038/nature12735. Epub 2013 Nov 20.
10
Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor.替莫唑胺对毒蕈碱 M3 受体的长作用持续时间和动力学选择性的分子基础。
J Med Chem. 2013 Nov 14;56(21):8746-56. doi: 10.1021/jm401219y. Epub 2013 Oct 25.